Global EconomyLivemint•1 min read•9/29/2026 (2h ago)

Small-cap pharma stock rallies 178% in 2026, extends winning run into fifth year; key factors behind rally

Small-cap pharma stock rallies 178% in 2026, extends winning run into fifth year; key factors behind rally
60-Word AI Digest

Cupid, a consumer wellness company, saw its shares surge 178% in 2026, driven by growing orders and expansion plans. This follows a 584% surge in 2025. The stock's recent rally has enhanced its market cap to ₹25,000 crore, benefiting retail investors significantly.

Key Takeaways

  • Cupid, a consumer wellness company, saw its shares surge 178% in 2026, driven by growing orders and expansion plans.
  • This follows a 584% surge in 2025.
  • The stock's recent rally has enhanced its market cap to ₹25,000 crore, benefiting retail investors significantly.

Cupid, a consumer wellness company, saw its shares surge 178% in 2026, driven by growing orders and expansion plans. This follows a 584% surge in 2025. The stock's recent rally has enhanced its market cap to ₹25,000 crore, benefiting retail investors significantly.

Original Publisher Attribution

This summary was curated from Livemint.

Read Original on Livemint
Small-cap pharma stock rallies 178% in 2026, extends winning run into fifth year; key factors behind rally — Loop60